PRTK - Paratek Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 5304.6M
Enterprise value 3251.15M
Trailing P/E N/A
Forward P/E 1-3.24
PEG Ratio (5 yr expected) 10.07
Price/sales (ttm)59.33
Price/book (mrq)3.56
Enterprise value/revenue 348.92
Enterprise value/EBITDA 6-2.65

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2017
Most-recent quarter (mrq)30 Jun 2018

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,860.89%

Management effectiveness

Return on assets (ttm)-23.42%
Return on equity (ttm)-101.27%

Income statement

Revenue (ttm)5.13M
Revenue per share (ttm)0.17
Quarterly revenue growth (yoy)-99.50%
Gross profit (ttm)-47.46M
EBITDA -94.64M
Net income avi to common (ttm)-100.7M
Diluted EPS (ttm)-3.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)264.05M
Total cash per share (mrq)8.32
Total debt (mrq)218.53M
Total debt/equity (mrq)255.62
Current ratio (mrq)7.88
Book value per share (mrq)2.70

Cash flow statement

Operating cash flow (ttm)-79.61M
Levered free cash flow (ttm)-44.12M

Trading information

Stock price history

Beta 0.65
52-week change 3-61.01%
S&P500 52-week change 317.34%
52-week high 326.10
52-week low 39.00
50-day moving average 310.02
200-day moving average 311.13

Share statistics

Avg vol (3-month) 3554.99k
Avg vol (10-day) 3318.66k
Shares outstanding 531.73M
Float 24.47M
% held by insiders 11.48%
% held by institutions 184.51%
Shares short (31 Aug 2018) 46.94M
Short ratio (31 Aug 2018) 410.21
Short % of float (31 Aug 2018) 422.24%
Short % of shares outstanding (31 Aug 2018) 421.87%
Shares short (prior month 31 Jul 2018) 46.31M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 329 Oct 2014
Ex-dividend date 431 Oct 2014
Last split factor (new per old) 21/12
Last split date 331 Oct 2014